These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2692227)

  • 1. A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children.
    Greenwood BM; Greenwood AM; Smith AW; Menon A; Bradley AK; Snow RW; Sisay F; Bennett S; Watkins WM; N'Jie AB
    Trans R Soc Trop Med Hyg; 1989; 83(2):182-8. PubMed ID: 2692227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of antimalarials and folate supplements on haematological indices and red cell folate levels in Gambian children.
    Fuller NJ; Bates CJ; Hayes RJ; Bradley AK; Greenwood AM; Tulloch S; Greenwood BM
    Ann Trop Paediatr; 1988 Jun; 8(2):61-7. PubMed ID: 2456731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
    Sulo J; Chimpeni P; Hatcher J; Kublin JG; Plowe CV; Molyneux ME; Marsh K; Taylor TE; Watkins WM; Winstanley PA
    Lancet; 2002 Oct; 360(9340):1136-43. PubMed ID: 12387962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Plasmodium falciparum in The Gambia to pyrimethamine, Maloprim and chloroquine.
    Panton LJ; Tulloch S; Bradley AK; Greenwood BM
    Trans R Soc Trop Med Hyg; 1985; 79(4):484-90. PubMed ID: 3909554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis.
    Otoo LN; Riley EM; Menon A; Byass P; Greenwood BM
    Trans R Soc Trop Med Hyg; 1989; 83(6):778-82. PubMed ID: 2515634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.
    Amukoye E; Winstanley PA; Watkins WM; Snow RW; Hatcher J; Mosobo M; Ngumbao E; Lowe B; Ton M; Minyiri G; Marsh K
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2261-4. PubMed ID: 9333058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.
    Dunyo S; Sirugo G; Sesay S; Bisseye C; Njie F; Adiamoh M; Nwakanma D; Diatta M; Janha R; Sisay Joof F; Temple B; Snell P; Conway D; Walton R; Cheung YB; Milligan P
    PLoS One; 2011; 6(6):e17371. PubMed ID: 21666744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis.
    Greenwood BM; David PH; Otoo-Forbes LN; Allen SJ; Alonso PL; Armstrong Schellenberg JR; Byass P; Hurwitz M; Menon A; Snow RW
    Trans R Soc Trop Med Hyg; 1995; 89(6):629-33. PubMed ID: 8594677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to malaria in young Gambian children after a two-year period of chemoprophylaxis.
    Otoo LN; Snow RW; Menon A; Byass P; Greenwood BM
    Trans R Soc Trop Med Hyg; 1988; 82(1):59-65. PubMed ID: 3051550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
    Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
    JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
    Alloueche A; Bailey W; Barton S; Bwika J; Chimpeni P; Falade CO; Fehintola FA; Horton J; Jaffar S; Kanyok T; Kremsner PG; Kublin JG; Lang T; Missinou MA; Mkandala C; Oduola AM; Premji Z; Robertson L; Sowunmi A; Ward SA; Winstanley PA
    Lancet; 2004 Jun; 363(9424):1843-8. PubMed ID: 15183620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine.
    Vrbova H; Gibney S; Gibson FD; Jolley D; Heywood PF; Stace J; Trenholme KR; Alpers MP
    P N G Med J; 1992 Dec; 35(4):275-84. PubMed ID: 1341089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Plasmodium falciparum to Maloprim after five years of targetted chemoprophylaxis in a rural area of The Gambia.
    Allen SJ; Otoo LN; Cooke GA; O'Donnell A; Greenwood BM
    Trans R Soc Trop Med Hyg; 1990; 84(5):666-7. PubMed ID: 2278063
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of two strategies for control of malaria within a primary health care programme in the Gambia.
    Greenwood BM; Greenwood AM; Bradley AK; Snow RW; Byass P; Hayes RJ; N'Jie AB
    Lancet; 1988 May; 1(8595):1121-7. PubMed ID: 2896957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique.
    Hogh B; Thompson R; Lobo V; Dgedge M; Dziegiel M; Borre M; Gottschau A; Streat E; Schapira A; Barreto J
    Acta Trop; 1994 Sep; 57(4):265-77. PubMed ID: 7810383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone.
    Trigg JK; Mbwana H; Chambo O; Hills E; Watkins W; Curtis CF
    Acta Trop; 1997 Feb; 63(2-3):185-9. PubMed ID: 9088432
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlorproguanil-dapsone for treating uncomplicated malaria.
    Bukirwa H; Garner P; Critchley J
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004387. PubMed ID: 15495106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study.
    Watkins WM; Brandling-Bennett AD; Nevill CG; Carter JY; Boriga DA; Howells RE; Koech DK
    Trans R Soc Trop Med Hyg; 1988; 82(3):398-403. PubMed ID: 3068855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.